GlassScriptPhysician profile
Nicholas Donohue
NPI 1457884488
$14,686.17
in general payments reported to CMS, 2019-2025
20 companies · $458 in 2025
The $458 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $75.29 · 2021: $10K · 2022: $394 · 2023: $2,470 · 2024: $791 · 2025: $458.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,520 · Travel and Lodging: $1,199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,519.81 |
| Travel and Lodging | $1,199.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $10,270.56 | 2021-2024 | Intracept |
| Relievant Medsystems, INC. | $1,133.84 | 2023 | Intracept |
| Nalu Medical, INC. | $987.55 | 2023-2024 | Nalu Neurostimulation System |
| Medtronic, INC. | $625.56 | 2021-2025 | Inceptiv |
| Abbott Laboratories | $589.97 | 2023-2025 | Eterna, Proclaim, Axium |
| Mml US, INC. | $320.39 | 2023-2025 | Reactiv8 |
| Terumo Medical Corporation | $141.32 | 2024 | Azur Cx Detachable, Hydropearl, Glidewire |
| Spr Therapeutics, INC | $113.72 | 2023 | Sprint Pns System |
| Nevro Corp. | $102.90 | 2022-2023 | Senza |
| Saluda Medical Americas, INC. | $92.31 | 2024-2025 | Evoke |
| Great Lakes Orthopedics | $75.29 | 2019 | |
| Convatec INC. | $63.07 | 2025 | |
| Spinal Simplicity, LLC | $38.76 | 2023-2024 | Ha Minuteman G3-R |
| Ossur Americas, INC. | $24.14 | 2024 | Miami J |
| Pacira Pharmaceuticals Incorporated | $23.12 | 2024 | Iovera, Zilretta, Exparel |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $22.05 | 2024 | Iconix, Procinch |
| Ibsa Pharma INC. | $16.93 | 2024 | Tirosint, Licart |
| Painteq LLC | $15.55 | 2023 | Painteq |
| Bioventus LLC | $14.83 | 2024 | Exogen Ultrasound Bone Healing System |
| Curonix LLC | $14.31 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Donohue listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.